May 5, 2000 Company founded by Austin & Eula Sequeira. Initiated development of Immunochromatographic tests for infectious diseases.

Nov. 2000 Accacia contracted to develop immunochromatographic (IC) strip test for Axxess Biotech ( Canada ).

Jan. 2002 Successful spin-off of Accacia Serum Products Inc., U.S. and Accacia Serum India Pvt. Ltd ( India )

Oct. 2002 Developed prototype handheld IC strip reader for diagnostic use.

Feb. 2003 Contracted by Spectral Diagnostics ( Canada ) to develop prototype IC readers for potential commercial use.

March 2004 Accacia awarded SBIR Phase I grant funding by U.S. Department of Homeland Security (HSARPA) for research titled “ Novel Aptamer:Peptide Based Assays for Homeland Security”

May 2004 Accacia International selected in competition after exclusion of sources for SBIR Phase-I funding by Defense Advanced Research Projects Agency (DARPA) project titled “Nanosphere Beacons for Real-Time Detection In-Vivo”

June 2004 Accacia partners with consortium of scientists from University of Texas at Austin, (Ellington Labs), Albert Einstein Institute and Harvard University to successfully win a four year NIH grant for the selection of RNA aptamers to HIV virus for use as diagnostic and potential therapeutic. Research titled “High throughput selection & characterization of aptamers”

June 2005 After successful completion of Phase I grant, Accacia was awarded a Phase II award from HSARPA for research titled “ Novel Aptamer:Peptide Based Assays for Homeland Security”

August 2005 Moved business & research operations to a larger facility in Austin , TX .

March 2007 Commenced contractual negotiations of two year grant from NIH (Division of Genetics and Developmental Biology ) in collaboration with University of Texas at Austin . “ T7 RNA polymerase engineering and RNA amplification ”

March 2007 Awarded SBIR Phase I contract from Department of Defense (Air Force) for research proposal entitled “Polyvalent Aptamer Networks”